MDC 0.00% $6.60 medlab clinical limited

Ann: Medlab Progresses Nasdaq Dual Listing, page-17

  1. 4,366 Posts.
    lightbulb Created with Sketch. 330
    Your asking the wrong person. Maybe contact the company?
    The market is more interested in unfounded medical claims and focusing more on supply of the product more than a registered pharmaceutical drug for pain management in replacement of opioid drugs.
 
watchlist Created with Sketch. Add MDC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.